This Week at FDA: Remote regulatory assessments guidance, 12-digit NDCs, and more

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy